ONCORUS

Oncorus, Inc. is a lean early-stage biotechnology company developing a next-generation immunotherapy platform to treat cancer. Oncorus was founded MPM Managing Director Mitch Finer, a well-known biotechnology entrepreneur. Oncorus is a leader in corporate philanthropy, and has taken a pledge to donate a portion of product sales to fund promising cancer research and to support cancer care in the developing world.

#People #Financial #Event #Website #More

ONCORUS

Social Links:

Twitter

Industry:

Biotechnology Medical Therapeutics

Founded:

2015-04-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.oncorus.com

Total Employee:

11+

Status:

Active

Contact:

(857)320-6402

Email Addresses:

[email protected]

Total Funding:

218.49 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics

Current Advisors List

luke-evnin_image

Luke Evnin Board Of Director @ Oncorus
Board_member

Current Employees Featured

lorena-lerner_image

Lorena Lerner
Lorena Lerner Vice President Research @ Oncorus
Vice President Research
2019-01-01

theodore-t-ashburn_image

Theodore T. Ashburn
Theodore T. Ashburn President & CEO @ Oncorus
President & CEO
2018-07-01

john-mccabe_image

John McCabe
John McCabe Chief Financial Officer @ Oncorus
Chief Financial Officer
2017-10-01

kenneth-greenberg_image

Kenneth Greenberg
Kenneth Greenberg Co-Founder @ Oncorus
Co-Founder
2015-04-01

not_available_image

Steve Harbin
Steve Harbin COO and Chief of Staff @ Oncorus
COO and Chief of Staff

scott-a-canute_image

Scott A. Canute
Scott A. Canute Director @ Oncorus
Director
2020-12-01

john-goldberg_image

John Goldberg
John Goldberg Chief Medical Officer @ Oncorus
Chief Medical Officer
2022-02-01

Founder

cyrus-mozayeni_image

Cyrus Mozayeni

kenneth-greenberg_image

Kenneth Greenberg

mitchell-finer_image

Mitchell Finer

Stock Details

Company's stock symbol is NASDAQ:ONCR

Investors List

k2-healthventures_image

Key Employee Changes

Date	New article
2022-05-10	Oncorus Announces Appointment of Richard Wanstall as Chief Financial Officer
2022-02-22	Oncorus Announces Promotion of John Goldberg, M.D. to Chief Medical Officer

Official Site Inspections

http://www.oncorus.com

Host Informations
Whois Informations

Loading ...